EXEL
Exelixis, Inc.
NASDAQ · Healthcare · Biotechnology · US
$59.01
−0.20%Forward multiples
Based on analyst estimates
- P/E forward
- 15.91x
- P/E 2026E
- 16.81x
- P/E 2027E
- 14.24x
- P/E 2028E
- 12.24x
- P/S forward
- 5.45x
Trailing multiples
Trailing twelve months
- P/E TTM
- 17.94x
- PEG TTM
- 1.41x
- Price / book
- 7.93x
- Price / sales
- 6.00x
- Price / cash flow
- 12.36x
Enterprise value
- Enterprise value
- $13.9B
- EV / sales
- 5.73x
- EV / EBITDA
- 13.41x
- EV / EBIT
- 14.36x
- Market cap
- $14.6B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jul 1, 2026